U.S. biotechs to speed work on Nipah vaccine as virus hits India
A global coalition set up a year ago to fight epidemics has struck a $25 million deal with two U.S. biotech companies to accelerate work on a vaccine against the brain-damaging Nipah virus that has killed 12 people in India.
U.S. biotechs to speed work on Nipah vaccine as virus hits India
Source: Virology News